 Vijaya Vemulakonda
Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ureteral Obstruction | 5 | 2021 | 29 | 3.670 |
Why?
| | Urologic Surgical Procedures | 8 | 2021 | 55 | 3.340 |
Why?
| | Hydronephrosis | 5 | 2021 | 23 | 2.730 |
Why?
| | Urology | 4 | 2018 | 28 | 2.330 |
Why?
| | Kidney Pelvis | 3 | 2021 | 19 | 2.030 |
Why?
| | Pediatrics | 4 | 2019 | 729 | 1.370 |
Why?
| | Urinary Bladder | 4 | 2016 | 103 | 1.210 |
Why?
| | Kidney Transplantation | 2 | 2022 | 248 | 1.080 |
Why?
| | Urologists | 2 | 2020 | 12 | 1.000 |
Why?
| | Qualitative Research | 4 | 2022 | 562 | 0.950 |
Why?
| | Electronic Health Records | 3 | 2019 | 486 | 0.920 |
Why?
| | Infant | 14 | 2021 | 5727 | 0.900 |
Why?
| | Multicystic Dysplastic Kidney | 1 | 2020 | 3 | 0.880 |
Why?
| | Kidney Diseases, Cystic | 1 | 2020 | 7 | 0.880 |
Why?
| | Biomedical Research | 2 | 2018 | 441 | 0.880 |
Why?
| | Hypospadias | 2 | 2018 | 15 | 0.870 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 862 | 0.860 |
Why?
| | Fasting | 1 | 2020 | 189 | 0.780 |
Why?
| | Stakeholder Participation | 1 | 2019 | 43 | 0.760 |
Why?
| | Urinary Tract Infections | 2 | 2018 | 90 | 0.760 |
Why?
| | Neurotoxicity Syndromes | 1 | 2018 | 11 | 0.750 |
Why?
| | Outpatients | 1 | 2020 | 159 | 0.750 |
Why?
| | Preoperative Care | 1 | 2020 | 226 | 0.740 |
Why?
| | Urinary Incontinence | 2 | 2016 | 46 | 0.730 |
Why?
| | Kidney Failure, Chronic | 1 | 2022 | 282 | 0.720 |
Why?
| | Anesthesia | 1 | 2018 | 61 | 0.710 |
Why?
| | Urinary Fistula | 1 | 2017 | 4 | 0.700 |
Why?
| | Prenatal Diagnosis | 2 | 2020 | 130 | 0.690 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 188 | 0.670 |
Why?
| | Parents | 2 | 2020 | 767 | 0.660 |
Why?
| | Epispadias | 1 | 2016 | 4 | 0.650 |
Why?
| | Bladder Exstrophy | 1 | 2016 | 13 | 0.650 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2016 | 3 | 0.640 |
Why?
| | Risk Assessment | 4 | 2018 | 2143 | 0.620 |
Why?
| | Vesico-Ureteral Reflux | 2 | 2020 | 15 | 0.610 |
Why?
| | Spinal Dysraphism | 1 | 2016 | 25 | 0.610 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2008 | 142 | 0.610 |
Why?
| | Hernia, Umbilical | 1 | 2014 | 7 | 0.550 |
Why?
| | Anus, Imperforate | 1 | 2014 | 17 | 0.540 |
Why?
| | Physicians | 1 | 2020 | 511 | 0.530 |
Why?
| | Urethra | 1 | 2014 | 35 | 0.530 |
Why?
| | Urogenital Abnormalities | 1 | 2014 | 32 | 0.530 |
Why?
| | Referral and Consultation | 1 | 2017 | 470 | 0.520 |
Why?
| | Wilms Tumor | 1 | 2013 | 52 | 0.500 |
Why?
| | Child | 15 | 2022 | 12453 | 0.500 |
Why?
| | Humans | 42 | 2022 | 128242 | 0.500 |
Why?
| | Tumor Burden | 1 | 2013 | 202 | 0.500 |
Why?
| | Decision Making | 1 | 2018 | 558 | 0.490 |
Why?
| | Patient Selection | 1 | 2015 | 479 | 0.480 |
Why?
| | Scoliosis | 1 | 2014 | 121 | 0.470 |
Why?
| | Botulinum Toxins, Type A | 3 | 2011 | 20 | 0.470 |
Why?
| | Data Collection | 1 | 2014 | 448 | 0.460 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 807 | 0.450 |
Why?
| | Ultrasonography, Prenatal | 3 | 2020 | 211 | 0.440 |
Why?
| | Child, Preschool | 10 | 2020 | 6811 | 0.430 |
Why?
| | Dextrans | 1 | 2009 | 51 | 0.390 |
Why?
| | Female | 31 | 2021 | 92196 | 0.380 |
Why?
| | Cystitis | 2 | 2005 | 18 | 0.370 |
Why?
| | Prune Belly Syndrome | 1 | 2007 | 7 | 0.360 |
Why?
| | Cultural Diversity | 1 | 2008 | 35 | 0.360 |
Why?
| | Hyaluronic Acid | 1 | 2009 | 148 | 0.350 |
Why?
| | Stomach Neoplasms | 1 | 2008 | 46 | 0.350 |
Why?
| | Retrospective Studies | 8 | 2019 | 8051 | 0.340 |
Why?
| | Male | 29 | 2020 | 90667 | 0.330 |
Why?
| | Engineering | 12 | 2018 | 47370 | 0.310 |
Why?
| | Social Responsibility | 12 | 2018 | 47385 | 0.310 |
Why?
| | Attitude | 12 | 2018 | 47516 | 0.310 |
Why?
| | Adenoma | 1 | 2007 | 145 | 0.310 |
Why?
| | Students | 12 | 2018 | 47688 | 0.310 |
Why?
| | Biocompatible Materials | 1 | 2009 | 274 | 0.310 |
Why?
| | Kidney | 2 | 2021 | 823 | 0.290 |
Why?
| | Infant, Newborn | 4 | 2022 | 3619 | 0.290 |
Why?
| | Education, Medical, Graduate | 1 | 2008 | 261 | 0.290 |
Why?
| | Neuromuscular Agents | 1 | 2005 | 18 | 0.280 |
Why?
| | Incidence | 3 | 2018 | 1791 | 0.270 |
Why?
| | Ultrasonography | 2 | 2021 | 569 | 0.270 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 569 | 0.270 |
Why?
| | Urethral Diseases | 2 | 2017 | 10 | 0.260 |
Why?
| | Prospective Studies | 3 | 2020 | 4425 | 0.260 |
Why?
| | Follow-Up Studies | 4 | 2019 | 3446 | 0.260 |
Why?
| | Clinical Competence | 1 | 2008 | 641 | 0.240 |
Why?
| | Sexual Development | 1 | 2022 | 11 | 0.240 |
Why?
| | Adenocarcinoma | 1 | 2008 | 591 | 0.240 |
Why?
| | Renal Replacement Therapy | 1 | 2022 | 38 | 0.240 |
Why?
| | Urography | 2 | 2014 | 6 | 0.230 |
Why?
| | Pregnancy | 2 | 2021 | 3839 | 0.220 |
Why?
| | Tertiary Care Centers | 2 | 2019 | 81 | 0.220 |
Why?
| | Adult | 18 | 2022 | 70001 | 0.210 |
Why?
| | Postoperative Complications | 3 | 2020 | 1517 | 0.210 |
Why?
| | Internship and Residency | 1 | 2008 | 680 | 0.210 |
Why?
| | Urinary Bladder, Neurogenic | 2 | 2018 | 21 | 0.210 |
Why?
| | Postoperative Period | 1 | 2020 | 200 | 0.200 |
Why?
| | Patient Portals | 1 | 2019 | 20 | 0.200 |
Why?
| | United States | 5 | 2020 | 8885 | 0.200 |
Why?
| | Cohort Studies | 3 | 2017 | 3676 | 0.190 |
Why?
| | Surveys and Questionnaires | 14 | 2020 | 50539 | 0.190 |
Why?
| | Renal Dialysis | 1 | 2022 | 244 | 0.190 |
Why?
| | Social Support | 1 | 2022 | 399 | 0.190 |
Why?
| | User-Computer Interface | 1 | 2019 | 129 | 0.190 |
Why?
| | Bacteriuria | 1 | 2018 | 6 | 0.190 |
Why?
| | Adolescent | 18 | 2022 | 60563 | 0.190 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2018 | 18 | 0.180 |
Why?
| | Disorders of Sex Development | 1 | 2018 | 27 | 0.180 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 361 | 0.170 |
Why?
| | Fetus | 1 | 2020 | 489 | 0.170 |
Why?
| | Analgesia | 1 | 2017 | 67 | 0.160 |
Why?
| | Reoperation | 1 | 2018 | 376 | 0.160 |
Why?
| | Global Health | 1 | 2018 | 250 | 0.160 |
Why?
| | Socialization | 12 | 2018 | 47368 | 0.150 |
Why?
| | Interviews as Topic | 12 | 2018 | 47819 | 0.150 |
Why?
| | Urination | 2 | 2014 | 22 | 0.150 |
Why?
| | Young Adult | 13 | 2022 | 55149 | 0.150 |
Why?
| | Curriculum | 12 | 2018 | 47915 | 0.150 |
Why?
| | Reconstructive Surgical Procedures | 1 | 2018 | 178 | 0.150 |
Why?
| | Longitudinal Studies | 12 | 2018 | 49312 | 0.150 |
Why?
| | Databases, Factual | 2 | 2017 | 820 | 0.150 |
Why?
| | Registries | 1 | 2022 | 1281 | 0.150 |
Why?
| | Postnatal Care | 1 | 2014 | 49 | 0.140 |
Why?
| | Cloaca | 1 | 2014 | 43 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2014 | 522 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 181 | 0.120 |
Why?
| | Cystoscopy | 2 | 2011 | 10 | 0.120 |
Why?
| | Sex Factors | 3 | 2018 | 1441 | 0.120 |
Why?
| | Urinary Retention | 1 | 2011 | 14 | 0.110 |
Why?
| | Treatment Outcome | 2 | 2021 | 6403 | 0.110 |
Why?
| | Ureteroscopy | 1 | 2009 | 10 | 0.100 |
Why?
| | Injections | 1 | 2009 | 110 | 0.100 |
Why?
| | Urologic Diseases | 1 | 2008 | 20 | 0.090 |
Why?
| | Anastomosis, Surgical | 1 | 2008 | 79 | 0.090 |
Why?
| | Electrocoagulation | 1 | 2007 | 22 | 0.090 |
Why?
| | Stomach | 1 | 2008 | 71 | 0.090 |
Why?
| | Risk Factors | 3 | 2018 | 6441 | 0.080 |
Why?
| | Educational Measurement | 1 | 2008 | 210 | 0.080 |
Why?
| | Urothelium | 1 | 2005 | 27 | 0.080 |
Why?
| | Laparoscopy | 1 | 2008 | 290 | 0.070 |
Why?
| | Colorado | 1 | 2014 | 3230 | 0.070 |
Why?
| | Administration, Intravesical | 1 | 2005 | 7 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 1698 | 0.070 |
Why?
| | Biomarkers | 1 | 2014 | 2583 | 0.070 |
Why?
| | Biopsy | 1 | 2007 | 751 | 0.070 |
Why?
| | Length of Stay | 1 | 2008 | 736 | 0.070 |
Why?
| | Program Evaluation | 1 | 2008 | 614 | 0.070 |
Why?
| | Adenosine Triphosphate | 1 | 2005 | 310 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 2266 | 0.070 |
Why?
| | Chronic Disease | 2 | 2005 | 1154 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2005 | 2177 | 0.060 |
Why?
| | Rats | 2 | 2005 | 4631 | 0.050 |
Why?
| | Age Factors | 2 | 2018 | 2277 | 0.050 |
Why?
| | Urolithiasis | 1 | 2018 | 6 | 0.050 |
Why?
| | Cryptorchidism | 1 | 2018 | 10 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2018 | 45 | 0.050 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 56 | 0.050 |
Why?
| | Urine | 1 | 2018 | 47 | 0.050 |
Why?
| | Constipation | 1 | 2018 | 44 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1098 | 0.040 |
Why?
| | Quality Improvement | 1 | 2020 | 665 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1463 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2018 | 2288 | 0.030 |
Why?
| | Injections, Intralesional | 1 | 2011 | 21 | 0.030 |
Why?
| | Urodynamics | 1 | 2011 | 22 | 0.030 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2011 | 33 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2011 | 166 | 0.020 |
Why?
| | Physical Therapy Modalities | 1 | 2011 | 191 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 730 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 864 | 0.020 |
Why?
| | Animals | 2 | 2005 | 25325 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2005 | 9 | 0.020 |
Why?
| | Mechanoreceptors | 1 | 2005 | 9 | 0.020 |
Why?
| | Osmotic Pressure | 1 | 2005 | 27 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2005 | 89 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2005 | 168 | 0.020 |
Why?
| | Sensory Receptor Cells | 1 | 2005 | 56 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2005 | 106 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2011 | 1983 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2005 | 286 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2005 | 2840 | 0.010 |
Why?
|
|
Vemulakonda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|